Find your path to Rob
338 people in our graph share verified history with Rob — schools, employers, funds. One of them is your warm intro.
Alan EzekowitzunlockedRob: together at University of Cape Town (1974–1977)
×2Rob: together at Pfizer
Rob: together at FDA
×5Rob: together at Amgen
About
Rob Scott served as Chief Medical Officer at AbbVie and currently holds the position of Chief Medical Officer and Head of R&D at ABIONYX Pharma, where the company is developing a sepsis therapy. He brings nearly four decades of executive leadership experience across drug discovery, development, strategic lifecycle planning, and medical affairs at major pharmaceutical and biotech companies, and maintains board and advisory positions at multiple biotech, venture capital, and private equity firms.
Experience
- ABIONYX PharmaChief Medical Officer & Head of R&Dcurrent2024 — present
- Confo TherapeuticsBoard Membercurrent2020 — present
- Draupnir BioBoard Membercurrent2020 — presentCopenhagen, Capital Region of Denmark, Denmark
- Variant BioBoard Membercurrent2020 — present
- OncoSpherixBoard Membercurrent2021 — presentAtlanta, Georgia, United States
- Bioethics InternationalAdvisorcurrent2017 — present
- Redx PharmaBoard Member2022 — 2024Manchester Area, United Kingdom
- ArisGlobalBoard Member2020 — 2024
- Windtree Therapeutics, Inc.Board Member2021 — 2024
- Morningside BioPharma AdvisoryStrategic Advisor2020 — 2023
- AbbVieChief Medical Officer, Head of Development2016 — 2020Greater Chicago Area
- Chicago Council on Science and Technology (C2ST)Board Member2019 — 2020Greater Chicago Area
- PhRMAR&D Leadership Forum2016 — 2020Greater Chicago Area
- TransCelerate BioPharma Inc.Board Member2016 — 2020Greater Chicago Area
- Kanan Therapeutics, Inc.Chairman of the Board2016 — 2018Los Angeles Metropolitan Area
- AmgenVice President, Global Development TA Head, Head Development Design Center2010 — 2016Los Angeles Metropolitan Area
- FDACommittee Member2012 — 2015Washington DC-Baltimore Area
- Cerenis TherapeuticsChief Medical Officer2008 — 2010Greater Toulouse Metropolitan Area
- AtheroGenicsChief Medical Officer, Executive Vice President of Research & Development2002 — 2007Atlanta Metropolitan Area
- PfizerVice President Cardiovascular & Metabolic Group1992 — 2002New York City Metropolitan Area
- Johnson & JohnsonMedical Advisor1987 — 1989City of Johannesburg, Gauteng, South Africa
Skills & more
Nonprofit Organizations5Clinical Development99Clinical Trials99Pharmaceutical Industry97Drug Development85Biotechnology67Clinical Research40Regulatory Affairs35Drug Discovery35Medicine29Life Sciences30Diabetes20
+12 more
FDACommercializationPharmacologyStrategyPharmaceuticsMedical DevicesBiopharmaceuticalsTherapeutic AreasR&DMedical AffairsLifesciencesCardiologyFrom Rob's professional profile.
Colleagues at Apollo Health Ventures
Agathe Wrisez
General Partner at Apollo Health Ventures
Alexandra Bause
Co-Founder and Venture Partner at Apollo Health Ventures
Anela Vukoja
COO at Apollo Health Ventures
Anne Marije van Harten
Investment Director at Apollo Health Ventures
Antoine Boulanger
Partner at Apollo Health Ventures
Christopher R. Shepard
Venture Partner at Apollo Health Ventures
Dr. Alexandra Bause
Co-Founder & Venture Partner at Apollo Health Ventures
Dr. Gerd Hummel
Venture Partner at Apollo Health Ventures
Frequently asked questions
- Who is Rob Scott?
- Rob Scott served as Chief Medical Officer at AbbVie and currently holds the position of Chief Medical Officer and Head of R&D at ABIONYX Pharma, where the company is developing a sepsis therapy. He brings nearly four decades of executive leadership experience across drug discovery, development, strategic lifecycle planning, and medical affairs at major pharmaceutical and biotech companies, and maintains board and advisory positions at multiple biotech, venture capital, and private equity firms.
- Where does Rob Scott work?
- Rob Scott is Advisor at Apollo Health Ventures.
- Where did Rob Scott go to school?
- Rob Scott studied at University of Cape Town (MbChB, Medicine); University of Cape Town (BSc, Microbiology and Biochemistry).
Same school
Also attended University of Cape Town268
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberJames DetweilerVP of Investments at Felicis VenturesAvron MarcusInvestor at Index VenturesLaurel BowdenPartner at 83NorthAlan EzekowitzInvestor at Third Rock VenturesAndy VitusPartner at Scale Venture Partners
+ 262 more
Shared employers
Also worked at Confo Therapeutics5
Also worked at Variant Bio3
Also worked at AbbVie44
Nick GasbarroChief of Staff at QED InvestorsCharles White, Ph.D.Principal at Illumina VenturesLaura QuockCBO-in-Residence at Versant VenturesManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next Ventures
+ 38 more
Also worked at Pfizer229
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 223 more